RA Capital Management, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), bought 1,795,000 shares at $2.48 ($4.5M) on 2013-11-12, disclosed to the SEC on 2013-11-13.
Open-market purchase of $4.5M ACHN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |